Upconversion Nanoparticle-Based Dot-Blot Immunoassay for Quantitative Biomarker Detection
Open Access
- 13 June 2024
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (25) , 10237-10245
Abstract
Dot-blot immunoassays are widely used for the user-friendly detection of clinical biomarkers. However, the majority of dot-blot assays have only limited sensitivity and are only used for qualitative or semiquantitative analysis. To overcome this limitation, we have employed labels based on photon-upconversion nanoparticles (UCNPs) that exhibit anti-Stokes luminescence and can be detected without optical background interference. First, the dot-blot immunoassay on a nitrocellulose membrane was optimized for the quantitative analysis of human serum albumin (HSA), resulting in a limit of detection (LOD) of 0.19 ng/mL and a signal-to-background ratio (S/B) of 722. Commercial quantum dots were used as a reference label, reaching the LOD of 4.32 ng/mL and the S/B of 3, clearly indicating the advantages of UCNPs. In addition, the potential of UCNP-based dot-blot for real sample analysis was confirmed by analyzing spiked urine samples, reaching the LOD of 0.24 ng/mL and recovery rates from 79 to 123%. Furthermore, we demonstrated the versatility and robustness of the assay by adapting it to the detection of two other clinically relevant biomarkers, prostate-specific antigen (PSA) and cardiac troponin (cTn), reaching the LODs in spiked serum of 9.4 pg/mL and 0.62 ng/mL for PSA and cTn, respectively. Finally, clinical samples of patients examined for prostate cancer were analyzed, achieving a strong correlation with the reference electrochemiluminescence immunoassay (recovery rates from 89 to 117%). The achieved results demonstrate that UCNPs are highly sensitive labels that enable the development of dot-blot immunoassays for quantitative analysis of low-abundance biomarkers.Keywords
Funding Information
- European Commission (CZ.02.1.01/0.0/0.0/18_046/0015974)
- Ministerstvo ?kolstv??, ml??de?e a t?lov??chovy (LM2023042)
- Grantov?? Agentura ?esk?? Republiky (GA22-27580S)
- ??stav analytick?? chemie, Akademie V?d ?esk?? Republiky (RVO: 68081715)
This publication has 53 references indexed in Scilit:
- Homogeneous fluorescence-based immunoassay via inner filter effect of gold nanoparticles on fluorescence of CdTe quantum dotsThe Analyst, 2012
- A homogeneous fluorescent sensor for human serum albuminJournal of Pharmaceutical and Biomedical Analysis, 2012
- Detection by using monoclonal antibodies of Yersinia enterocolitica in artificially-contaminated porkMicrobiology and Immunology, 2011
- Quantum Dots in Cell BiologyJournal of Histochemistry & Cytochemistry, 2011
- Development of a dot-blot assay for screening monoclonal antibodies to low-molecular-mass drugsAnalytical Biochemistry, 2010
- Prostate-specific antigen in the early detection of prostate cancerCanadian Medical Association Journal, 2007
- Western blottingMethods, 2006
- Evaluation and Management of Prostate-specific Antigen Recurrence After Radical Prostatectomy for Localized Prostate CancerJapanese Journal of Clinical Oncology, 2005
- Rapid diagnosis of rabies in humans and animals by a dot blot enzyme immunoassayInternational Journal of Infectious Diseases, 2004
- Semiquantitative analysis of urinary low protein levels using silver dot blot assayJournal of Clinical Laboratory Analysis, 2001